Literature DB >> 8989371

Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.

J P Goff1, D S Shields, S S Boggs, J S Greenberger.   

Abstract

The role of recombinant hematopoietic growth factors in radiation repair has become a subject of increasing interest in both clinical and basic radiobiology. Combinations of cytokines such as hepatocyte growth factor, interleukin (IL)-3, IL-11, kit ligand, GM-CSF and erythropoietin were used to study the in vitro radiation dose response of human cord blood CD34+ hematopoietic progenitor cells using clonogenic survival assays. CD34+ cells were isolated by immunomagnetic selection and irradiated at 8 cGy/min. Irradiated cells were plated in methylcellulose with or without added cytokines, and hematopoietic colonies including CFU-GM, BFU-E and CFU-GEMM were scored on day 14. The radiation response characteristics of BFU-E and CFU-GEMM were similar for all culture conditions tested. The D0 values for BFU-E ranged between 1.29 and 2.40 Gy and n between 1.0 and 1.4. The D0 values for CFU-GEMM ranged from 86 cGy to 2.02 Gy and n between 1.0 and 1.5. The D0 for CFU-GM grown without added factors was 1.03 Gy. With single cytokine stimulation (IL-3, IL-11 or varying concentrations of HGF), D0 values ranged from 1.11 to 1.44 Gy. With the combination of IL-3, GM-CSF, kit ligand and HGF, D0 values were not significantly altered and ranged between 1.61 and 2.60 Gy. In contrast, the combination of IL-11 and HGF produced an increase in the shoulder of the radiation survival curve (n = 3.35). No increase in the shoulder was detected for any of the other conditions tested (n = 1.0-1.7). Thus the combination of HGF and IL-11 increased the radiation survival of hematopoietic progenitor cells forming CFU-GM. Understanding the mechanism by which combinations of early-acting growth factors support postirradiation recovery of primitive clonogenic hematopoietic cells may be relevant to the design of clinical protocols for improving hematopoietic recovery after total-body irradiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989371

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

Review 1.  Current status of tumor radiogenic therapy.

Authors:  Feng-Ling Min; Hong Zhang; Wen-Jian Li
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

2.  Involved field radiation post autologous stem cell transplantation in lymphoma patients is associated with major haematological toxicities.

Authors:  A Toren; R Nagler; A Nagler
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

3.  Synergistic protecting effect of cord blood CD34+ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated mice.

Authors:  Yong Zhang; Chaohua Guo; Hongbin Zhang; Shiwu Dong
Journal:  Int J Hematol       Date:  2009-06-16       Impact factor: 2.490

4.  Characteristics of human CD34+ cells exposed to ionizing radiation under cytokine-free conditions.

Authors:  Junya Ishikawa; Naoki Hayashi; Masaru Yamaguchi; Satoru Monzen; Ikuo Kashiwakura
Journal:  J Radiat Res       Date:  2015-04-15       Impact factor: 2.724

5.  Oxidative stress due to radiation in CD34(+) hematopoietic progenitor cells: protection by IGF-1.

Authors:  Konstantina Floratou; Efstathia Giannopoulou; Anna Antonacopoulou; Marina Karakantza; George Adonakis; Dimitrios Kardamakis; Panagiota Matsouka
Journal:  J Radiat Res       Date:  2012-07-10       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.